基于蛋白质组学的乌竹榆汤治疗慢性偏头痛脑肠协调关键靶点研究

IF 3.1 3区 医学 Q2 CHEMISTRY, ANALYTICAL
Meijing Li , Zhimin Song , Keshu Wang , Qi Wang , Xiaomeng Guo , Ziwei Zhou , Jingjing Xu , Sha Wu , Muxin Gong
{"title":"基于蛋白质组学的乌竹榆汤治疗慢性偏头痛脑肠协调关键靶点研究","authors":"Meijing Li ,&nbsp;Zhimin Song ,&nbsp;Keshu Wang ,&nbsp;Qi Wang ,&nbsp;Xiaomeng Guo ,&nbsp;Ziwei Zhou ,&nbsp;Jingjing Xu ,&nbsp;Sha Wu ,&nbsp;Muxin Gong","doi":"10.1016/j.jpba.2025.117064","DOIUrl":null,"url":null,"abstract":"<div><div>Chronic migraine is a debilitating disorder often accompanied by gastrointestinal dysfunction. However, the targets and mechanisms underlying this interaction in migraine remain unclear. Wuzhuyu Decoction (WZYD), a traditional Chinese medicine, has shown efficacy in alleviating migraine and gastrointestinal symptoms. However, its mechanisms of brain-gut coordination remain unclear. This study investigates the mechanisms of WZYD on the brainstem and colon in chronic migraine model rats based on proteomics. A chronic migraine model was induced via meningeal inflammation, followed by WZYD administration. WZYD increased pain thresholds, reduced CGRP and Fos, while elevating 5-HT. Proteomic analysis identified proteins significantly regulated by WZYD in the brainstem and colon respectively, primarily involved in inflammation and signal transduction. UHPLC-Q-Exactive-MS/MS revealed blood-absorbed components of WZYD, and network analysis predicted 959 potential targets. Proteomics-based PPI analysis combined with network analysis of blood-absorbed components identified DDO, PRKACB, and MAPK8 as key potential targets regulated by WZYD. These findings were validated through molecular docking, mRNA and protein expression analysis. WZYD reduced Iba-1, TNF-<em>α</em>, IL-6, SP, DDO, PRKACB, and MAPK8, while elevating IL-10 and GLP-2 levels, mitigating neuroinflammation and intestinal inflammation. These findings suggest WZYD could alleviate chronic migraine by regulating key protein targets and coordinating anti-inflammatory responses in the brain and gut.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"265 ","pages":"Article 117064"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Key targets of brain-gut coordination in Wuzhuyu decoction treating chronic migraine based on proteomics\",\"authors\":\"Meijing Li ,&nbsp;Zhimin Song ,&nbsp;Keshu Wang ,&nbsp;Qi Wang ,&nbsp;Xiaomeng Guo ,&nbsp;Ziwei Zhou ,&nbsp;Jingjing Xu ,&nbsp;Sha Wu ,&nbsp;Muxin Gong\",\"doi\":\"10.1016/j.jpba.2025.117064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Chronic migraine is a debilitating disorder often accompanied by gastrointestinal dysfunction. However, the targets and mechanisms underlying this interaction in migraine remain unclear. Wuzhuyu Decoction (WZYD), a traditional Chinese medicine, has shown efficacy in alleviating migraine and gastrointestinal symptoms. However, its mechanisms of brain-gut coordination remain unclear. This study investigates the mechanisms of WZYD on the brainstem and colon in chronic migraine model rats based on proteomics. A chronic migraine model was induced via meningeal inflammation, followed by WZYD administration. WZYD increased pain thresholds, reduced CGRP and Fos, while elevating 5-HT. Proteomic analysis identified proteins significantly regulated by WZYD in the brainstem and colon respectively, primarily involved in inflammation and signal transduction. UHPLC-Q-Exactive-MS/MS revealed blood-absorbed components of WZYD, and network analysis predicted 959 potential targets. Proteomics-based PPI analysis combined with network analysis of blood-absorbed components identified DDO, PRKACB, and MAPK8 as key potential targets regulated by WZYD. These findings were validated through molecular docking, mRNA and protein expression analysis. WZYD reduced Iba-1, TNF-<em>α</em>, IL-6, SP, DDO, PRKACB, and MAPK8, while elevating IL-10 and GLP-2 levels, mitigating neuroinflammation and intestinal inflammation. These findings suggest WZYD could alleviate chronic migraine by regulating key protein targets and coordinating anti-inflammatory responses in the brain and gut.</div></div>\",\"PeriodicalId\":16685,\"journal\":{\"name\":\"Journal of pharmaceutical and biomedical analysis\",\"volume\":\"265 \",\"pages\":\"Article 117064\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmaceutical and biomedical analysis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0731708525004054\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525004054","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

摘要

慢性偏头痛是一种衰弱性疾病,常伴有胃肠功能障碍。然而,偏头痛中这种相互作用的目标和机制尚不清楚。中药乌竹鱼汤(WZYD)已显示出缓解偏头痛和胃肠道症状的功效。然而,其脑肠协调机制尚不清楚。本研究从蛋白质组学的角度探讨WZYD对慢性偏头痛模型大鼠脑干和结肠的作用机制。通过脑膜炎症诱导慢性偏头痛模型,然后给药WZYD。WZYD增加疼痛阈值,降低CGRP和Fos,同时升高5-HT。蛋白质组学分析发现WZYD分别在脑干和结肠中显著调节蛋白,主要参与炎症和信号转导。uhplc - q - ex- MS/MS分析了WZYD的血吸收成分,网络分析预测了959个潜在靶点。基于蛋白质组学的PPI分析结合血液吸收成分的网络分析,发现DDO、PRKACB和MAPK8是WZYD调控的关键潜在靶点。这些发现通过分子对接、mRNA和蛋白表达分析得到了验证。WZYD降低Iba-1、TNF-α、IL-6、SP、DDO、PRKACB和MAPK8,同时升高IL-10和GLP-2水平,减轻神经炎症和肠道炎症。这些发现表明,WZYD可以通过调节关键蛋白靶点和协调大脑和肠道的抗炎反应来缓解慢性偏头痛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Key targets of brain-gut coordination in Wuzhuyu decoction treating chronic migraine based on proteomics
Chronic migraine is a debilitating disorder often accompanied by gastrointestinal dysfunction. However, the targets and mechanisms underlying this interaction in migraine remain unclear. Wuzhuyu Decoction (WZYD), a traditional Chinese medicine, has shown efficacy in alleviating migraine and gastrointestinal symptoms. However, its mechanisms of brain-gut coordination remain unclear. This study investigates the mechanisms of WZYD on the brainstem and colon in chronic migraine model rats based on proteomics. A chronic migraine model was induced via meningeal inflammation, followed by WZYD administration. WZYD increased pain thresholds, reduced CGRP and Fos, while elevating 5-HT. Proteomic analysis identified proteins significantly regulated by WZYD in the brainstem and colon respectively, primarily involved in inflammation and signal transduction. UHPLC-Q-Exactive-MS/MS revealed blood-absorbed components of WZYD, and network analysis predicted 959 potential targets. Proteomics-based PPI analysis combined with network analysis of blood-absorbed components identified DDO, PRKACB, and MAPK8 as key potential targets regulated by WZYD. These findings were validated through molecular docking, mRNA and protein expression analysis. WZYD reduced Iba-1, TNF-α, IL-6, SP, DDO, PRKACB, and MAPK8, while elevating IL-10 and GLP-2 levels, mitigating neuroinflammation and intestinal inflammation. These findings suggest WZYD could alleviate chronic migraine by regulating key protein targets and coordinating anti-inflammatory responses in the brain and gut.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.70
自引率
5.90%
发文量
588
审稿时长
37 days
期刊介绍: This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome. Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信